We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

St. Jude Ends Investor Suit Over Cardiac Devices For $39M

Law360, Los Angeles (July 7, 2016, 8:24 PM EDT) -- St. Jude Medical Inc. agreed to pay more than $39 million to settle a long-running securities class action over whether the company and its executives downplayed dangers with lead wires on its heart rhythm management devices, according to papers filed in Minnesota Thursday.

St. Jude will pay the sum to end litigation that kicked off in December 2012 with a 178-page complaint alleging the company lied to investors about the quality of new leads on cardiac rhythm management devices branded the Riata, Durata, QuickSite and QuickFlex,...
To view the full article, register now.




Case Information

Case Title

Forsta AP-Fonden et al v. St. Jude Medical, Inc. et al

Case Number




Nature of Suit



Joan N. Ericksen

Date Filed

December 7, 2012

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.